140 related articles for article (PubMed ID: 15563315)
1. Lymphangiogenic growth factors as markers of tumor metastasis.
Stacker SA; Williams RA; Achen MG
APMIS; 2004; 112(7-8):539-49. PubMed ID: 15563315
[TBL] [Abstract][Full Text] [Related]
2. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
3. Tumor-induced lymphangiogenesis: a target for cancer therapy?
Thiele W; Sleeman JP
J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
[TBL] [Abstract][Full Text] [Related]
4. [Lymphangiogenesis and tumor progression].
Vittet D; Feige JJ
Bull Cancer; 2007 Oct; 94(10):881-6. PubMed ID: 17964982
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
[No Abstract] [Full Text] [Related]
6. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
8. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE; Detmar M
J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis and tumor metastasis: myth or reality?
Pepper MS
Clin Cancer Res; 2001 Mar; 7(3):462-8. PubMed ID: 11297234
[TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.
Bierer S; Herrmann E; Köpke T; Neumann J; Eltze E; Hertle L; Wülfing C
Oncol Rep; 2008 Oct; 20(4):721-5. PubMed ID: 18813809
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenesis in human gynaecological cancers.
Van Trappen PO; Pepper MS
Angiogenesis; 2005; 8(2):137-45. PubMed ID: 16211357
[TBL] [Abstract][Full Text] [Related]
12. Tumor lymphangiogenesis and melanoma metastasis.
Rinderknecht M; Detmar M
J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
[TBL] [Abstract][Full Text] [Related]
14. Pathways targeting tumor lymphangiogenesis.
Wissmann C; Detmar M
Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
[TBL] [Abstract][Full Text] [Related]
15. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
16. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer.
Teramoto S; Arihiro K; Koseki M; Kataoka T; Asahara T; Ohdan H
Hiroshima J Med Sci; 2008 Jun; 57(2):73-8. PubMed ID: 18717190
[TBL] [Abstract][Full Text] [Related]
17. The biology of vascular endothelial growth factors.
Tammela T; Enholm B; Alitalo K; Paavonen K
Cardiovasc Res; 2005 Feb; 65(3):550-63. PubMed ID: 15664381
[TBL] [Abstract][Full Text] [Related]
18. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site.
van der Schaft DW; Pauwels P; Hulsmans S; Zimmermann M; van de Poll-Franse LV; Griffioen AW
Cancer Lett; 2007 Aug; 254(1):128-36. PubMed ID: 17442484
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]